Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies



Rating:

Share or cite this content

Citations should be made in the following way:
N. Migueres (Strasbourg, France), A. Poirot (Strasbourg, France), N. Zhang (Ghent, Belgium), C. Bachert (Ghent, Belgium), F. De Blay (Strasbourg, France). Staphylococcal Enterotoxins sensitization and response of Omalizumab in severe atopic and non atopic asthma. 881

Member's Comments

No comment yet.

Related content which might interest you: Omalizumab in severe adult atopic dermatitis associated to mild asthma treated with omalizumab Source: Annual Congress 2012 - Asthma: assessment and treatment Year: 2012 Role of atopic dermatitis as a risk factor for allergic rhinitis in children Source: Annual Congress 2010 - Paediatric epidemiology: asthma and associated factors Year: 2010 Omalizumab in children with severe persistent allergic asthma Source: Annual Congress 2010 - Managing asthma and allergic disease in children Year: 2010 The relation between atopic and non-atopic asthma and PPD response Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases Year: 2009 Persistency of treatment response to omalizumab in patients with severe allergic (IgE-mediated) asthma Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009 The role of mepolizumab in atopic and nonatopic severe asthma with persistent eosinophilia Source: Eur Respir J 2014; 44: 239-241 Year: 2014 Allergen-specific IgE patterns in allergic diseases of respiratory system with atopic dermatitis. Source: International Congress 2019 – Asthma and allergies worldwide Year: 2019 Combined childhood flexural eczema and rhinitis predicts atopic asthma but not non-atopic asthma Source: Annual Congress 2010 - New insights in the epidemiology of asthma Year: 2010 From atopic dermatitis to asthma what drives the allergic march? Source: Eur Respir J 2003; 22: Suppl. 45, 137s Year: 2003 Exhaled NO in atopic and non atopic asthma children and in asthma exacerbations Source: Eur Respir J 2002; 20: Suppl. 38, 337s Year: 2002 Omalizumab decreases IgE production in patients with severe allergic asthma Source: Annual Congress 2012 - Aspects of clinical asthma Year: 2012 The structure of sensitization to aeroallergens in children with atopic bronchial asthma Source: International Congress 2019 – Asthma and allergies worldwide Year: 2019 Rhinitis prevalence and its relationship with asthma, atopic dermatitis and allergic sensitization in school children Source: Annual Congress 2008 - Risk factors for asthma versus asthma control Year: 2008 Cough sensitivity changes in allergic rhinitis and atopic dermatitis without clinical symptoms from lower airways Source: Eur Respir J 2002; 20: Suppl. 38, 188s Year: 2002 Immunotherapy prevents the development of asthma in subjects with allergic rhinitis Source: Eur Respir J 2001; 18: Suppl. 33, 482s Year: 2001 Evaluation of six-year allergen immunotherapy in allergic rhinitis and allergic asthma Source: Eur Respir J 2006; 28: Suppl. 50, 439s Year: 2006 Airway inflammation in non-eosinophilic atopic asthma: comparisons with eosinophilic atopic asthma and COPD Source: Eur Respir J 2005; 26: Suppl. 49, 733s Year: 2005 Specific allergen immunotherapy of asthma combined with allergic rhinitis Source: Eur Respir J 2006; 28: Suppl. 50, 441s Year: 2006 Common allergic disease: atopic eczema and allergic rhinitis Source: Annual Congress 2006 - PG7 - Paediatric respiratory medicine: allergy for paediatric pulmonologists Year: 2006 Treatment of co-morbid allergic asthma and perennial allergic rhinitis with the anti-IgE agent omalizumab Source: Eur Respir J 2003; 22: Suppl. 45, 203s Year: 2003